Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial Evaluating the Efficacy and Safety of a Microbiome-Focused Oral Food Supplement in Adults With Moderate Evaporative Dry Eye Disease Associated With Meibomian Gland Dysfunction

NCT07453212 is registered in ClinicalTrials.gov with Varol TUNALI as lead sponsor.

NCT NCT07453212
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07453212 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial Evaluating the Efficacy and Safety of a Microbiome-Focused Oral Food Supplement in Adults With Moderate Evaporative Dry Eye Disease Associated With Meibomian Gland Dysfunction
Lead sponsor
Varol TUNALI
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
March 1, 2026
Completion date
November 30, 2026
Enrollment
130 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye, evaporative dry eye disease, meibomian gland dysfunction (disorder)